Literature DB >> 33732698

MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B/HOXC4/PD-L1 Axis.

Lei Liu1, Ting Yu2, Yanping Jin3, Wei Mai4, Jing Zhou5, Chunbo Zhao5.   

Abstract

The relevance of microRNA-15a (miR-15a) to autoimmunity has been reported. Herein, we intended to probe the potential roles of miR-15a shuttled by adipose-derived mesenchymal stem cells (adMSCs)-derived extracellular vesicles (Evs) in colorectal cancer (CRC). Initially, CRC cells were treated with interferon gamma (IFN-γ) to screen out differentially expressed genes by transcriptome sequencing. Following a 24-h co-culture with 20 μM adMSCs-derived Evs, CRC cell viability, migration, invasion, and apoptosis were assessed. After the determination of histone lysine demethylase 4B (KDM4B) as our target, its regulatory miRNA was predicted by the bioinformatics websites and verified by dual-luciferase and RNA pull-down assays. Intriguingly, KDM4B downregulated homeobox C4 (HOXC4) expression, while HOXC4 bound to the promoter sequence of programmed death-ligand 1 (PD-L1). Thus, we conducted rescue experiments to study the role of KDM4B and HOXC4. Finally, we evaluated the effects of adMSCs on CRC cell growth and immune evasion through in vivo tumorigenesis experiments. AdMSCs-derived Evs overexpressing miR-15a repressed proliferation, migration, and invasion, while it promoted the apoptosis of CRC cells via downregulation of KDM4B. These in vivo findings were reproduced in vitro on CRC immune evasion. Collectively, adMSCs-derived Evs overexpressing miR-15a restricted the immune evasion of CRC via the KDM4B/HOXC4/PD-L1 axis.
Copyright © 2021 Liu, Yu, Jin, Mai, Zhou and Zhao.

Entities:  

Keywords:  HOXC4; KDM4B; adipose-derived mesenchymal stem cells; colorectal cancer; immune evasion; microRNA-15a

Year:  2021        PMID: 33732698      PMCID: PMC7959841          DOI: 10.3389/fcell.2021.629893

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  34 in total

1.  MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer.

Authors:  Jinjin Zhang; Juchao Ren; Shengjie Hao; Fang Ma; Yan Xin; Wenxiao Jia; Yundong Sun; Zhifang Liu; Han Yu; Jihui Jia; Wenjuan Li
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

2.  JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.

Authors:  Li Zhao; Wenjuan Li; Wen Zang; Zhifang Liu; Xia Xu; Han Yu; Qing Yang; Jihui Jia
Journal:  Clin Cancer Res       Date:  2013-09-27       Impact factor: 12.531

3.  KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the β-catenin/STT3 signaling pathway.

Authors:  Zhiyan Ruan; Minhua Liang; Manxiang Lai; Ling Shang; Xiangliang Deng; Xinguo Su
Journal:  Int Immunopharmacol       Date:  2019-12-04       Impact factor: 4.932

4.  Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model.

Authors:  Kyeongsoo Jeong; Yeong Jun Yu; Jae Young You; Won Jong Rhee; Jeong Ah Kim
Journal:  Lab Chip       Date:  2020-01-16       Impact factor: 6.799

5.  MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10.

Authors:  Xiao-Fang Liu; Run-Qi Wang; Bo Hu; Meng-Chuan Luo; Qiu-Ming Zeng; Hao Zhou; Kun Huang; Xiao-Hua Dong; Yue-Bei Luo; Zhao-Hui Luo; Huan Yang
Journal:  Clin Immunol       Date:  2016-02-01       Impact factor: 3.969

6.  IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.

Authors:  K Abiko; N Matsumura; J Hamanishi; N Horikawa; R Murakami; K Yamaguchi; Y Yoshioka; T Baba; I Konishi; M Mandai
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

7.  The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.

Authors:  C Wilson; L Qiu; Y Hong; T Karnik; G Tadros; B Mau; T Ma; Y Mu; J New; R J Louie; S Gunewardena; A K Godwin; O W Tawfik; J Chien; K F Roby; A J Krieg
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

8.  Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.

Authors:  Hailong Ma; Wenyi Yang; Liming Zhang; Shuli Liu; Mei Zhao; Ge Zhou; Lizhen Wang; Shufang Jin; Zhiyuan Zhang; Jingzhou Hu
Journal:  Br J Cancer       Date:  2018-12-17       Impact factor: 7.640

9.  Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer.

Authors:  Kevin Chih-Yang Huang; Shu-Fen Chiang; William Tzu-Liang Chen; Tsung-Wei Chen; Ching-Han Hu; Pei-Chen Yang; Tao-Wei Ke; K S Clifford Chao
Journal:  Cancers (Basel)       Date:  2020-02-17       Impact factor: 6.639

10.  KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.

Authors:  Haijie Li; Jingqin Lan; Guihua Wang; Kaixuan Guo; Caishun Han; Xiaolan Li; Junbo Hu; Zhixin Cao; Xuelai Luo
Journal:  J Exp Clin Cancer Res       Date:  2020-01-13
View more
  11 in total

1.  miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation.

Authors:  Li Li; Shijun Yu; Jingde Chen; Ming Quan; Yong Gao; Yandong Li
Journal:  Cell Death Discov       Date:  2022-06-27

Review 2.  Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.

Authors:  Carl Randall Harrell; Ana Volarevic; Valentin G Djonov; Nemanja Jovicic; Vladislav Volarevic
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

3.  Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer.

Authors:  Sachin Kumar; Jyoutishman Saikia; Surender K Sharawat; Prabhat S Malik; Sunil Kumar; Anant Mohan
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 4.  The Roles of Mesenchymal Stem Cells in Gastrointestinal Cancers.

Authors:  Ze Xiang; Menglu Hua; Zhou Hao; Huang Biao; Chaojie Zhu; Guanghua Zhai; Jian Wu
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

Review 5.  The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation.

Authors:  Zhiwei Fan; Changyue Wu; Miaomiao Chen; Yongying Jiang; Yuanyuan Wu; Renfang Mao; Yihui Fan
Journal:  Acta Pharm Sin B       Date:  2021-09-16       Impact factor: 14.903

Review 6.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy.

Authors:  María Cecilia Sanmartin; Francisco Raúl Borzone; María Belén Giorello; Gustavo Yannarelli; Norma Alejandra Chasseing
Journal:  Front Bioeng Biotechnol       Date:  2022-04-14

Review 7.  JMJD family proteins in cancer and inflammation.

Authors:  Wang Manni; Xue Jianxin; Hong Weiqi; Chen Siyuan; Shi Huashan
Journal:  Signal Transduct Target Ther       Date:  2022-09-01

Review 8.  Current insight into the regulation of PD-L1 in cancer.

Authors:  Zhuandi Liu; Xibao Yu; Ling Xu; Yangqiu Li; Chengwu Zeng
Journal:  Exp Hematol Oncol       Date:  2022-07-30

Review 9.  The Effects of Mesenchymal Stem Cell on Colorectal Cancer.

Authors:  Jintao Yuan; Zhiping Wei; Xinwei Xu; Dickson Kofi Wiredu Ocansey; Xiu Cai; Fei Mao
Journal:  Stem Cells Int       Date:  2021-07-24       Impact factor: 5.443

Review 10.  Mesenchymal Stem Cell-Derived Extracellular Vesicles: Pleiotropic Impacts on Breast Cancer Occurrence, Development, and Therapy.

Authors:  Yiling Guo; Yujia Zhai; Longyuan Wu; Yazhuo Wang; Puzhen Wu; Lixia Xiong
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.